慢性疼痛中基于生物标志物的剂量-反应关系:生理闭环脊髓电刺激的首个证据
该研究在超过600例脊髓电刺激(SCS)患者中,评估了基于诱发电复合动作电位(ECAP)的生理闭环控制(PCLC)技术所测量的神经生理指标与疼痛缓解的关系。结果显示,治疗剂量、高于神经激活阈值的时间及SCS治疗准确性与疼痛缓解存在显著关系,并首次提供了SCS中剂量-反应关系的证据。结论认为更高的剂量、更多时间超过ECAP阈值及更高准确性均与更好的患者结局相关。
要点
- 基于ECAP的PCLC技术可量化SCS治疗剂量并连续测量神经激活。
- 超过600例SCS患者中,客观电生理指标与疼痛缓解显著相关。
- 首次在SCS中观察到剂量-反应关系,支持个体化优化治疗。
核心结论
- 在超过600例SCS患者中,更高的治疗剂量、更多高于ECAP阈值的时间及更高的SCS准确性均与更好的疼痛缓解相关。
- 首次提供了SCS中基于生物标志物的剂量-反应关系的证据。
研究设计与样本
- 研究评估了超过600例SCS患者的神经生理指标(治疗剂量、高于神经激活阈值的时间、SCS治疗准确性)与疼痛缓解的关系。
主要发现
- 在患者群体中,客观指标与疼痛缓解之间存在显著关系。
- 首次显示了SCS中的剂量-反应关系。
临床怎么用
- 基于ECAP的PCLC技术可处方个体化精确刺激剂量并连续测量神经激活,有助于客观指导SCS治疗优化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: In spinal cord stimulation (SCS) therapy, electricity is the medication delivered to the spinal cord for pain relief. In contrast to conventional medication where dose is determined by desired therapeutic plasma concentration, there is lack of equivalent means of determining dose delivery in SCS. In open-loop (OL) SCS, due to the dynamic nature of the epidural space, the activating electric field delivered is inconsistent at the level of the dorsal columns. Recent Food and Drug Administration guidance suggests accurate and consistent therapy delivered using physiologic closed-loop control (PCLC) devices can minimize underdosage or overdosage and enhance medical care. PCLC-based evoked compound action potential (ECAP)-controlled technology provides the ability to prescribe a precise stimulation dose unique to each patient, continuously measure neural activation, and objectively inform SCS therapy optimization. METHODS: Neurophysiological indicator metrics of therapy dose, usage above neural activation threshold, and accuracy of SCS therapy were assessed for relationship with pain reduction in over 600 SCS patients. RESULTS: Significant relationships between objective metrics and pain relief across the patient population are shown, including first evidence for a dose-response relationship in SCS. CONCLUSIONS: Higher dose, more time over ECAP threshold, and higher accuracy are associated with better outcomes across patients. There is potential to optimize individual patient outcomes based on unique objective measurable electrophysiological inputs.
引用
- Muller L, Pope J, Verrills P, et al. First evidence of a biomarker-based dose-response relationship in chronic pain using physiological closed-loop spinal cord stimulation. Reg Anesth Pain Med. 2025. PMID: 38508591. doi:10.1136/rapm-2024-105346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。